Don't Clone Humans!
By Rudolf Jaenisch and Ian Wilmut,
Science
| 03. 30. 2001
The successes in animal cloning suggest to some that the technology
has matured sufficiently to justify its application to human cloning.
An in vitro fertilization specialist and a reproductive physiologist
recently announced their intent to clone babies within a year's time
(1). There are many social and ethical reasons why we would never
be in favor of copying a person. However, our immediate concern is
that this proposal fails to take into account problems encountered
in animal cloning.
Since the birth of Dolly the sheep (2), successful cloning has been
reported in mice (3), cattle (4), goats (5), and pigs (6, 7), and
enough experience has accumulated to realize the risks. Animal cloning
is inefficient and is likely to remain so for the foreseeable future.
Cloning results in gestational or neonatal developmental failures.
At best, a few percent of the nuclear transfer embryos survive to
birth and, of those, many die within the perinatal period. There is
no reason to believe that the outcomes of attempted human cloning
will be any different. The few cloned ruminants that have survived
to...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...